Peter Attia· MD
when you combine a PCSK9 inhibitor with a statin you actually do get a reduction of LP little a whereas if statin by itself is anywhere from no reduction to in some studies an actual increase in LP little a
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
when you combine a PCSK9 inhibitor with a statin you actually do get a reduction of LP little a whereas if statin by itself is anywhere from no reduction to in some studies an actual increase in LP little a
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
we're seeing about a 30% reduction in LP little a sometimes as high as a 50% reduction in LP little a when patients are taking pcsk9 inhibitors with or without statins